Purpose
Uses: Temporarily relieves symptoms of cold, flu, sore throat.
Cinnabar Dandelion Cold Relief
FDA Label NDC 48951-3102
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc for the product Cinnabar Dandelion Cold Relief (NDC 48951-3102). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding purpose, dosage & administration, otc-active ingredient, inactive ingredient, keep out of reach of children, do not use section, ask doctor section, pregnancy or breast feeding section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Directions: Take at first hint of symptoms. Dissolve under tongue. Take 4 times daily, up to every 1-2 hours as needed. Age 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: ask a doctor.
Otc-Active Ingredient
Active Ingredients: Taraxacum e pl. tota 2X, Agropyrum e rad. 3X, Kali carb. e cinere Fagi 10X, Cinnabaris 20X, all HPUS.
Inactive Ingredient
Inactive Ingredient: Sucrose, Pyrite 3X.
Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Do Not Use Section
Warnings:
Do not use if allergic to any ingredient. Do not use if safety seal is broken or missing.
Ask Doctor Section
Consult a doctor if symptoms are serious or persist for 3 days, if you are diabetic or intolerant of sugar.
Pregnancy Or Breast Feeding Section
If you are pregnant or nursing, consult a doctor before use.
Questions Section
Questions? Uriel Pharmacy
866 642-2858 East Troy, WI 53120
www.urielpharmacy.com
NDC 48951-3102-2
Principal Display Panel
Cinnabar Dandelion
Cold Relief
Homeopathic Pellets
net wt. 1 oz.
Cinnabar Dandelion Pellets Bottle Label (Cindanp02)
* Please review the disclaimer below.
